Neos Therapeutics (NEOS) Reports Q4 Loss of $1.14/Share

Neos Therapeutics (NASDAQ: NEOS) reported Q4 EPS of ($1.14), versus ($0.57) reported last year. Revenue for the quarter came in at $3.5 million, versus $1.66 million reported last year.

For earnings history and earnings-related data on Neos Therapeutics (NEOS) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22